Work Statics:
|
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Old cases (follow up) |
9169 |
5978 |
7466 |
10144 |
12061 |
13685 |
New cases |
783 |
520 |
627 |
685 |
673 |
875 |
Admissions in ward |
1111 |
753 |
1304 |
1658 |
1988 |
2095 |
Admissions in Ped nephro ICU |
174 |
123 |
137 |
204 |
170 |
297 |
Procedures done |
IJV HD Catheter |
158 |
223 |
143 |
345 |
272 |
236 |
Femoral HD Catheter |
18 |
27 |
39 |
78 |
68 |
42 |
IJV Permcath |
08 |
00 |
04 |
04 |
04 |
06 |
AVF |
12 |
20 |
34 |
37 |
47 |
152 |
Acute PD |
36 |
17 |
69 |
52 |
64 |
35 |
Native Renal Biopsy |
81 |
54 |
91 |
104 |
45 |
74 |
Graft Kidney Biopsy |
14 |
26 |
56 |
84 |
96 |
72 |
Therapeutic Plasma Exchange |
No. of Patients |
19 |
24 |
20 |
30 |
46 |
32 |
Sessions done |
123 |
182 |
214 |
231 |
435 |
356 |
Indications for TPE |
1. HUS |
14 |
13 |
09 |
10 |
22 |
16 |
2. ABMR |
04 |
09 |
06 |
11 |
15 |
07 |
3. FSGS recurrence |
01 |
02 |
01 |
02 |
01 |
00 |
4. ABOi transplant recipient |
- |
- |
- |
01 |
02 |
01 |
5. Desensitization |
- |
- |
04 |
06 |
01
03 |
02
06 |
Hemodialysis details: |
Old patients on HD |
10 |
25 |
33 |
59 |
90 |
93 |
New patients on HD added |
27 |
35 |
55 |
56 |
39 |
51 |
Patients undergone transplant |
08 |
13 |
15 |
14 |
26 |
26 |
Drop out/expired |
04 |
14 |
09 |
11 |
10 |
10 |
Presently on mHD at the end of the year |
25 |
33 |
59 |
90 |
93 |
106 |
No. of sessions done HD in a year at institute |
3244 |
2594 |
4591 |
3975 |
4633 |
5323 |
Pts getting mHD at peripheral GDP center |
10 |
17 |
23 |
41 |
60 |
80 |
CAPD details: |
Old patients on CAPD |
21 |
11 |
09 |
11 |
11 |
17 |
New patients added |
08 |
09 |
17 |
18 |
18 |
20 |
Patients undergone transplant |
0 |
0 |
0 |
02 |
01 |
03 |
Drop out/expired |
10 |
05 |
05 |
12 |
09 |
06 |
No. of patients shifted to mHD |
08 |
06 |
09 |
02 |
02 |
11 |
Presently on CAPD at the end of the year |
11 |
09 |
11 |
11 |
17 |
16 |
Transplantation details: |
Living related Kidney Transplant |
30 |
19 |
13 |
18 |
15 |
27 |
Deceased donor Kidney Transplant |
10 |
09 |
18 |
26 |
22 |
22 |
Hospital has in-house 24*7 laboratory, histopathology lab, immunology lab, radiology services, provision for real-time US guided Kidney biopsy, in house CT scan, Radionuclide scan facilities, urodynamics and actively running interventional radiology department.
State-of-art-treatment facilities available at par with international standards and recommendations:
- Low Density Lipoprotein- Apheresis (LDL-A) is indicated in children with Multi-Drug Resistant Nephrotic Syndrome. IKDRC-ITS is the first center in India successfully offering LDL-A as a therapeutic modality for multi-drug resistant nephrotic syndrome.
No of children who received LDL-A treatment |
11 |
Compete response |
07 |
Partial remission |
01 |
No response |
02 |
Death |
01 |
- Hereditary Tyrosinemia Type 1 is an inherited disorder with autosomal recessive inheritance that affects primarily the liver and kidney. It’s treatment has been revolutionized by Nitisinone, eliminating the need for liver transplantation eventually required when chronic liver disease develops. Now this breakthrough treatment is available at IKDRC pharmacy.
|
2023 |
2024 |
2025(till July 2025) |
No. of children diagnosed with HT- type 1 |
06 |
08 |
4 |
No. of children on treatment with Nitisinone |
05 |
11 |
15 |
No. of children who expired |
01 Before Nitisinone was made available |
1 Due to disease progression |
0 |
- Nephropathic Cystinosis is an autosomal recessive inherited genetic disorder where amino acid cystine accumulates in the body cells and tissues including Fanconi syndrome in the kidneys. Early diagnosis and treatment with cysteamine are critical to manage these children and delay progression to end stage kidney failure.
|
2024 |
2025(till July 2025) |
Total no. of children diagnosed with cystinosis |
08 |
10 |
No. of children on cysteamine |
08 |
09 |
No. of newly diagnosed cases |
03 |
02 |
No. of children with cystinosis on dialysis |
00 |
00 |
Received transplant |
02 |
02 |
Lost to follow up |
00 |
01 |
- Nephrogenetics is the study of genetic basis of kidney diseases. It encompasses how genetic variations influence the development, function, and susceptibility to kidney disorders. The well-equipped genetic laboratory at IKDRC-ITS enables the accurate diagnosis of various inherited conditions in children with kidney diseases enabling proper prognosis, appropriate treatment as well as familial screening and prenatal counselling.
Suspected Phenotypes |
Till 2023 |
2024 |
Nephrotic syndrome |
120 |
28 |
Cystic kidney disease |
56 |
10 |
Kidney stone work up |
52 |
11 |
Tubulopathy |
45 |
07 |
other |
27 |
29+ 22 reports pending |
Lost to follow up |
00 |
01 |









